Dihexa Vial
Dihexa is a synthetic, angiotensin IV-derived peptidomimetic engineered for high-affinity interaction with hepatocyte growth factor (HGF). Designed strictly for laboratory research use only, the lyophilized Dihexa vial serves as an essential tool for investigators studying neuroplasticity, dendritic spine formation, and neurodegenerative disease models. Institutional researchers rely on analytical-grade Dihexa to probe c-Met receptor dimerization cascades in controlled in vitro and animal models.
Quick answer
Dihexa is a synthetic, angiotensin IV-derived peptidomimetic engineered for high-affinity interaction with hepatocyte growth factor (HGF). Designed strictly for laboratory research use only, the lyophilized Dihexa vial serves as an essential tool for investigators studying neuroplasticity, dendritic spine formation, and neurodegenerative disease models. Institutional researchers rely on analytical-grade Dihexa to probe c-Met receptor dimerization cascades in controlled in vitro and animal models.
Key takeaways
- A [Dihexa](/research-peptides/dihexa) vial contains a high-purity, lyophilized powder of the small-molecule peptidomimetic N-hexanoic-Tyr-Ile-(6) aminohexanoic amide, designed strictly for in vitro and laboratory research applications.
- [Dihexa](/research-peptides/dihexa) (molecular formula: C27H44N4O5, molecular weight: 504.66 g/mol) is a hexanoic acid-modified tripeptide derivative.
- The primary mechanism of action characterized for [Dihexa](/research-peptides/dihexa) involves its binding to hepatocyte growth factor (HGF).
- In vitro assays utilizing primary hippocampal and cortical neuronal cultures demonstrate that [Dihexa](/research-peptides/dihexa) administration promotes rapid dendritic spine growth.
Overview and Definition of the Dihexa Research Vial
A Dihexa vial contains a high-purity, lyophilized powder of the small-molecule peptidomimetic N-hexanoic-Tyr-Ile-(6) aminohexanoic amide, designed strictly for in vitro and laboratory research applications. Highly regarded in preclinical neurobiology, Dihexa acts as a potent hepatocyte growth factor (HGF) potentiator, binding with picomolar affinity to facilitate c-Met receptor dimerization and drive robust synaptogenesis in neuronal cell cultures.
Unlike native neuropeptides that suffer from rapid enzymatic degradation, Dihexa was intentionally designed to possess metabolic stability, making it a valuable tool in neurodegenerative research. In preclinical settings, researchers evaluate the Dihexa 10mg vial to observe its impact on neural circuit repair, synaptic density, and signal transduction cascades. Every unit synthesized for PX1 Research is held to rigid quality benchmarks, ensuring that physical properties, bioactivity, and chemical identity remain consistent across experimental trials.
Chemical Structure and Molecular Identity
Dihexa (molecular formula: C27H44N4O5, molecular weight: 504.66 g/mol) is a hexanoic acid-modified tripeptide derivative. Its chemical structure incorporates a hexanoyl cap at the N-terminus attached to L-tyrosyl-L-isoleucyl residues coupled with a 6-aminohexanoic acid moiety. This specific chemical configuration protects the molecule from cleavage by aminopeptidases, a common limitation observed with unmodified endogenous oligopeptides.
In biochemical assays, the lipid-like hexanoyl domain enhances cell membrane permeability while maintaining high specificity for its primary target receptor. When analyzing raw material via HPLC and mass spectrometry protocols, researchers will observe a single prominent peak corresponding to the 504.66 Da monoisotopic mass. Understanding the molecular characteristics of this compound is fundamental when designing controlled concentration gradients in culture media or physiological buffer solutions.
Mechanism of Action: HGF/c-Met Signaling Pathway
The primary mechanism of action characterized for Dihexa involves its binding to hepatocyte growth factor (HGF). HGF is a multi-functional cytokine that, upon binding to its receptor tyrosine kinase, c-Met, initiates autophosphorylation and activates downstream signaling cascades essential for cell survival, tissue regeneration, and structural plasticity.
Preclinical studies indicate that Dihexa binds to HGF with high affinity (Ki = 10^-12 M), facilitating the dimerization of HGF molecules. This dimerization allows HGF to effectively bind and cross-activate c-Met receptors even at sub-threshold endogenous HGF concentrations. Activated c-Met subsequently engages the mitogen-activated protein kinase (MAPK/ERK) and phosphoinositide 3-kinase (PI3K/AKT) pathways. Detailed analyses of the Dihexa mechanism of action reveal that these intracellular cascades regulate cytoskeletal remodeling, actin polymerization, and protein synthesis required for forming new synaptic contacts.
Preclinical Findings in Synaptogenesis and Neuroplasticity
In vitro assays utilizing primary hippocampal and cortical neuronal cultures demonstrate that Dihexa administration promotes rapid dendritic spine growth. Quantitative morphometric analyses reveal increased spine density, elevated postsynaptic density protein 95 (PSD-95) expression, and enhanced synaptophysin staining following exposure to picomolar concentrations of the compound.
In animal models of cognitive decline and neurodegeneration—such as aged rodent cohorts and transgenic APP/PS1 mouse models of Alzheimer's disease—preclinical evaluations show that Dihexa crosses the blood-brain barrier and restores spatial memory performance in Barnes maze and Morris water maze testing. Researchers exploring the broader catalog of high-purity research peptides frequently utilize Dihexa as a benchmark control when evaluating novel small molecules intended for synaptic repair.
Reconstitution Guidelines and Solvent Selection for Lab Use
Lyophilized Dihexa exhibits distinct solubility characteristics compared to hydrophilic signaling peptides. Due to its hydrophobic N-terminal hexanoyl modification, Dihexa exhibits limited solubility in pure aqueous solutions such as standard 0.9% sterile saline or bacteriostatic water.
For optimal reconstitution, primary stock solutions should be prepared using dimethyl sulfoxide (DMSO) or sterile ethanol to fully dissolve the cake. Once initial solubilization in DMSO is achieved, the stock solution can be further diluted into phosphate-buffered saline (PBS) or cell culture media, maintaining a final DMSO concentration below 0.1% to prevent cytotoxicity in cell cultures. Investigators can refer to our detailed reconstitution guide for exact volumetric and concentration calculations required in micro-molar and nano-molar laboratory assays.
Analytical Quality Control: Verification Standards
To ensure valid and reproducible experimental outcomes, every Dihexa vial supplied by PX1 Research undergoes rigorous testing in ISO 17025 accredited analytical facilities. Given the precision required in neurobiological research, chemical impurities or endotoxin contamination can confound electrophysiological and cellular assays.
Our multi-step quality assurance process verifies: reverse-phase high-performance liquid chromatography (RP-HPLC) purity (>99%), mass spectrometry (ESI-MS) identity matching, residual solvent analysis (GC-MS), and chromogenic LAL endotoxin testing (<0.01 EU/mg). Every lot is accompanied by a publicly verifiable Certificate of Analysis (COA), guaranteeing that institutional labs receive uncompromising chemical standards manufactured exclusively within GMP-compliant US facilities.
Comparative Analysis: Dihexa vs. Other Neurotrophic Research Peptides
When designing preclinical protocols to evaluate cognitive enhancement or synaptic plasticity, researchers often evaluate Dihexa alongside other established peptide compounds. While Dihexa operates primarily through HGF/c-Met receptor potentiation, compounds like Semax research peptides act predominantly through brain-derived neurotrophic factor (BDNF) upregulation and monoaminergic modulation.
Similarly, Selank 5mg targets GABAergic signaling and immune-modulatory pathways, whereas Dihexa focuses specifically on structural dendritic spine density and synaptogenesis. For a comprehensive overview of compounds investigated for neurostructural signaling, researchers can consult our synaptogenesis research overview to select the optimal peptide profile for their specific experimental design.
Storage Stability and Handling Protocols
Lyophilized Dihexa vials are highly stable when stored under controlled environment conditions. Sealed vials should be stored at -20°C for long-term preservation, protected from direct light exposure and atmospheric moisture. Under these freeze conditions, the lyophilized powder remains stable for up to 24 months without noticeable degradation.
Following reconstitution in organic solvents or buffered media, solutions should be divided into single-use aliquots and stored at -80°C to avoid repeated freeze-thaw cycles. Repeated temperature fluctuations cause mechanical stress on the peptidomimetic backbone, leading to precipitation or partial oxidation over time. All reconstitution procedures should be performed inside a certified Class II biological safety cabinet using sterile lab consumables.
Institutional Sourcing and Procurement from PX1 Research
PX1 Research provides university laboratories, pharmaceutical institutes, and private research entities with reliable access to research-grade compounds. Each Dihexa vial is synthesized in North American facilities, ensuring rigid supply chain control, lot traceability, and rapid fulfillment.
Orders placed before daily cutoffs ship same-day from our dual distribution centers in California and Arizona. Institutional procurement departments seeking bulk quantities, customized vial sizing, or specialized lot documentation can apply for institutional wholesale access to obtain dedicated account management and volume pricing tiering.
Frequently Asked Questions
What is a Dihexa vial used for in laboratory research?
A Dihexa vial is used in preclinical laboratory research to investigate synaptogenesis, dendritic spine growth, HGF/c-Met signaling, and neurodegenerative disease mechanisms in cellular and animal models.
How should a Dihexa vial be reconstituted?
Because of its hydrophobic hexanoyl cap, Dihexa should first be dissolved in a organic solvent such as DMSO before diluting into aqueous solutions like PBS or cell culture media for in vitro testing.
What purity level is guaranteed for PX1 Research Dihexa vials?
Every Dihexa vial from PX1 Research is verified via RP-HPLC to exceed 99% purity, with molecular identity confirmed by mass spectrometry and endotoxin levels tested below 0.01 EU/mg.
Is Dihexa water-soluble?
Dihexa has low solubility in pure water or standard saline due to its lipophilic modification. Dissolving in 100% laboratory-grade DMSO prior to aqueous buffer dilution is recommended.
Can Dihexa be used for human consumption or therapeutic treatment?
No. Dihexa is strictly manufactured and sold as a research compound for laboratory in vitro and preclinical experimentation only. It is not approved for human or veterinary use.
What is the primary receptor target of Dihexa?
Dihexa targets hepatocyte growth factor (HGF), binding with picomolar affinity to potentiate HGF-induced c-Met receptor dimerization and downstream signaling.
How should reconstituted Dihexa solutions be stored?
Reconstituted solutions should be aliquoted into single-use microcentrifuge tubes and stored at -80°C to prevent degradation from multiple freeze-thaw cycles.
Where are PX1 Research Dihexa vials manufactured and shipped from?
PX1 Research compounds are manufactured in US-based GMP-compliant facilities and shipped directly from distribution hubs in California and Arizona with same-day dispatch M-F.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.